Advisory: Alert incorrectly tagged to Sparx Group Co Ltd withdrawn

An alert on research-based development-stage biopharmaceutical
company SparX Biopharmaceutical announcing first patient dosed
with SPX-303 injection was incorrectly tagged to Japan-based
holding company Sparx Group Co Ltd  8739.T , an unrelated
company, and has been withdrawn. 
    There will be no substitute. 
    
    
STORY_NUMBER: TUAB8TFR7 
STORY_DATE: 11/04/2024 
STORY_TIME:[07:11:33 PM GMT]

 ((Bangalore.newsroom@thomsonreuters.com))

Recent news on SPARX

See all news